Product Information
PYRIDOSTIGMINE ER 180 MG TAB is a generic product labeled by Oceanside Pharmaceuticals, priced at $5.1534 per EA under NDC 68682030130. Its NADAC has been published 509 times since Jan 6, 2016.
FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
180 mg/1
Manufacturer
Oceanside PharmaceuticalsNDC
68682030130
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
9/17/2025
Active Ingredients
PYRIDOSTIGMINE BROMIDEApproval Type
Authorized Generic (NDA)
FDA Application
NDA011665FDA Approved
Before 1982
TE Code
AB
On Market Since
1/12/1959
Pharmacological Classes
Price Statistics
The NADAC for PYRIDOSTIGMINE ER 180 MG TAB has been published 509 times since Jan 6, 2016, and over the history we have for it it has declined 65.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $5.1534 per EA |
|---|---|
| All-time high | $15.5612 (Mar 16, 2016) |
| All-time low | $1.6459 (May 22, 2024) |
| Median price | $6.0939 |
| Average price | $7.2725 |
| Largest weekly change | +97.2% (Aug 21, 2024) |
| Weeks tracked | 509 |
| Tracking since | Jan 6, 2016 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
+48.4%
5Y
+11.4%
All
-65.1%
Last surveyed Oct 1, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Oceanside Pharmaceuticals manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
pyridostigmine bromide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Cholinesterase Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PYRIDOSTIGMINE ER 180 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for PYRIDOSTIGMINE ER 180 MG TAB, manufactured by Oceanside Pharmaceuticals, is $5.1534 per EA (NDC 68682030130), effective Oct 1, 2025.
How has the price of PYRIDOSTIGMINE ER 180 MG TAB changed over time?
Over the history we have for it, the NADAC for PYRIDOSTIGMINE ER 180 MG TAB has declined 65.1%. It has been tracked across 509 weekly CMS publications since Jan 6, 2016.
What are the highest and lowest recorded NADAC prices for PYRIDOSTIGMINE ER 180 MG TAB?
Since Jan 6, 2016, the NADAC for PYRIDOSTIGMINE ER 180 MG TAB has ranged from a low of $1.6459 (May 22, 2024) to a high of $15.5612 (Mar 16, 2016), with a median of $6.0939 per EA.
Are there cheaper alternatives to PYRIDOSTIGMINE ER 180 MG TAB?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as PYRIDOSTIGMINE ER 180 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures PYRIDOSTIGMINE ER 180 MG TAB?
PYRIDOSTIGMINE ER 180 MG TAB (NDC 68682030130) is labeled by Oceanside Pharmaceuticals, and CMS classifies it as a generic product.